Skip to content

Comparitive study of Ritu Haritaki Rasayana along with combination inhaler and combination inhaler alone to control Bronchial Asthma in young adults of age group 19 to 39 years

Assessment of synergistic effect of Ritu Haritaki Rasayana in Shishir Ritu along with combination inhaler in Tamaka Shwasa w.s.r. to Bronchial Asthma among young adults: A Randomized Controlled Trial - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/089973
Enrollment
80
Registered
2025-07-02
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J454- Moderate persistent asthma

Interventions

None listed

Sponsors

Dr Trushali Dashrath Kumbhalkar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed patients of Bronchial Asthma on combination inhaler of ICS/LABA (Budesonide 200mcg & Formoterol Fumarate 6mcg). Age group : Young adult 20 to 39 years. WHO Ayurveda symptoms score for Tamaka Shwasa less than 47 Peak Expiratory Flow Rate more than 300L/min Blood oxygen saturation (Spo2) more than 92 percent.

Exclusion criteria

Exclusion criteria: Patients of Acute Severe Asthma. WHO Ayurveda symptom score for Tamaka Shwasa more than 47 H/O Tuberculosis, Chronic Obstructive Pulmonary Disease, Emphysema, other complicated respiratory diseases. K/C/O Hypertension, Diabetes mellitus & Cardiac involvement. Patients with frequent H/O hospitalisation due to Status Asthmaticus. Patients classically contraindicated for Haritaki administration (pregnancy, underweight, who has undergone bloodletting, condition of excessive hunger, thirst & heat stroke).

Design outcomes

Primary

MeasureTime frame
This study may be useful to control asthma especially during Shishir Ritu when symptoms get flared up due to cold weather.Timepoint: This study may be useful to control asthma especially during Shishir Ritu when symptoms get flared up due to cold weather. The outcome will be assessed at 8 weeks and follow up will be taken after every 20 days in Shishir Ritu.

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Trushali Dashrath Kumbhalkar

Shri Ayurved Mahavidyalaya, Nagpur

archanabelge@gmail.com9420007324

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026